Tag: Liver Disease: Misc.
Guidelines Developed for Management of Alcohol-Associated Liver Disease
Multidisciplinary integrated care model with hepatology, addiction medicine providers, social workers should be promoted
Study Looks at Alcohol Intake, Mortality Link in Steatotic Liver Disease
For those with low risk of advanced fibrosis, hazard ratio was increased with consumption of 7.4 g/day or more
Prevalence of NAFLD Set to Increase to 34.3 Percent in 2050
NAFLD set to cause 19,300 new cases of HCC and 4,200 new cases of liver transplant per year by 2050
High-Risk Patients Awaiting Liver Transplant Benefit Most From Living Donors
Benefit was most evident in wait-listed cirrhosis patients with moderate-to-severe frailty
Sarcopenia Worsens Liver Transplant Outcomes for Patients With Cirrhosis
Sarcopenia tied to longer intensive care unit stay, more major complications, higher postoperative mortality
Hepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men
Since 2017, leading cause of HCC is NAFLD among women; increases in ALD- and NAFLD-HCC seen since 2015
Rates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy
Lower treatment retention rates seen with 30-day, out-of-pocket costs ≥$150
Technical Variant Graft Usage Affects Pediatric Liver Transplant Waitlist Mortality
Higher technical variant graft usage from living or deceased donor linked to lower waitlist mortality in pediatric liver transplant candidates
Recommendations Developed for Management of Acute Liver Failure
Comprehensive testing is essential to elucidate diagnosis and exclude underlying chronic liver disease
Bulevirtide Linked to Decline in Hepatitis D Virus RNA Levels
Normalization of alanine aminotransferase also seen with bulevirtide 2- or 10-mg
